The market is reeling under extreme pressure. The Sensex fell 300 pts and recovered a bit to 26570.57 down 269.93 points or 1 percent. the Nifty down 90.55 points or 1.1 percent at 8033.90. About 717 shares advanced, 1501 shares declined, and 126 shares are unchanged.
Pharma major Glenmark Pharma gained 1.6 percent intraday on getting final approval from United States Food & Drug Administration for psoriasis drug. "Glenmark Pharmaceuticals Inc. USA has been granted final approval by the USFDA for Calcipotriene Cream, 0.005 percent, the therapeutic equivalent of Dovonex Cream, 0.005 percent of Leo Pharma A/S, said the company in its filing. Glenmark will commence shipping of Calcipotriene cream immediately, it added.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com/
✆ - 0731-6554125 | Toll Free - 1800-3010-2007
0 comments:
Post a Comment